The Indianapolis-based drugmaker also reaffirmed its 2025 revenue guidance but noted that the calculation was based on existing tariff and trade policies.

Eli Lilly revenue surged in the latest quarter on steady sales of Mounjaro and other weight-loss treatments in its portfolio. The drug maker logged net income of $2.76 billion, or $3.06 a share, up ...

Shares of Eli Lilly fell in premarket trading Thursday after the pharmaceutical giant's lowered profit projections outweighed ...

INDIANAPOLIS (AP) — INDIANAPOLIS (AP) — Eli Lilly and Co. (LLY) on Thursday reported first-quarter profit of $2.76 billion. The Indianapolis-based company said it had net income of $3.06 per share.

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

In this article, we are going to take a look at where Eli ... Lilly and Company (NYSE:LLY) in a report published on April 9. A 37.73% increase from current levels is implied by its consensus price ...

The stock of U.S. pharmaceutical giant Eli Lilly (LLY) is up 3% on news that rival Pfizer (PFE) has ended development of its experimental weight loss pill. Discover outperforming stocks and invest ...

Since I downgraded the stock, shares have seen upside of only 0.2%. That compares to the 1 ... Eli Lilly has a bright future ahead. Having said that, such a high-quality company demands a high ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... which translates to around 1/5th of the country’s entire national output. Holz said that the country’s major ...

ATLANTA, April 11, 2025 /PRNewswire/ -- On April 01, 2025, OrderlyMeds received a Cease-and-Desist letter from Eli Lilly regarding the ... your path on a GLP-1 medication may be your first ...

In light of the recent options history for Eli Lilly ... In the last month, 2 experts released ratings on this stock with an average target price of $1006.0. Unusual Options Activity Detected ...